Why the study?
Does severe hypoalbuminemia affect the predictive value of the APACHE II score for mortality in severely ill patients?
Does severe hypoalbuminemia affect the predictive value of the APACHE II score for mortality in severely ill patients?
Severe hypoalbuminemia significantly increases mortality risk beyond what is predicted by the APACHE II score, indicating the score is less accurate in this specific patient population.
Answers are grounded in this paper and cite their sources.
APACHE II underpredicts mortality in severe hypoalbuminemia; hypothesis-generating for albumin-adjusted risk models in ICU cohorts.
The APACHE II score predicts mortality in severely ill patients. This score does not account for the serum albumin level. Ninety-three patients (28 with serum albumin levels less than 2.5 g/dL [group I] and 65 with serum albumin levels greater than or equal to 2.5 [group II]) were retrospectively reviewed. Patients were comparable in age, APACHE II score, and compliance with required protein needs. Patients with severe hypoalbuminemia had nearly double the death rate of patients with mildly low or normal albumin concentrations (54% compared with 29%). The death rate in the severely hypoalbuminemic patients was 5.1-fold higher than would be predicted by their APACHE II score. The death rate in those patients with mildly low or normal albumin levels had only a 1.9-fold higher rate than would be predicted by their APACHE II score. It is concluded that severe hypoalbuminemia increases the risk of death significantly higher than would be predicted by the APACHE II score. APACHE II score is not as accurate in a severely hypoalbuminemic population.
No takes yet. Share an insight, caveat, or question.
Pollak et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: